Trial intelligence / Profile preview

Methylphenidate effect on brain growth factor in children and adolescents with ADHD

IRCT201108067237N1Phase 2Completed

Sponsor
Guilan University of Medical Sciences
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Guilan University of Medical Sciences. Started Sep 2011; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on IRCT201108067237N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201108067237N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call